Centogene_Logo.png
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
May 15, 2024 17:17 ET | Centogene NV
Reported Full Year 2023 total revenues of 2% growth at €48.5 millionSecured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company owned...
Centogene_Logo.png
CENTOGENE Announces Preliminary Full Year 2023 Revenue
January 18, 2024 06:30 ET | Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
Centogene_Logo.png
CENTOGENE Reports First Half 2023 Financial Results
September 07, 2023 17:00 ET | Centogene NV
First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue...
edgeTI-Press.png
Edge Total Intelligence Inc. Reports Second Quarter 2023 and Consolidated 2023 Results
August 29, 2023 19:39 ET | Edge Total Intelligence Inc.
ARLINGTON, Va., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Edge Total Intelligence Inc. (TSXV: CTRL, OTC: UNFYF, FSE: Q5i)(“edgeTI”, “we”, “our” or the “Company”), a leader in real-time digital operations,...
Centogene_Logo.png
CENTOGENE Reports Full Year 2022 Financial Results
May 16, 2023 18:25 ET | Centogene NV
Full Year 2022 total revenues with double-digit growth of 12% at €47.5 million, in line with prior guidanceSignificant expansion of gross profit margin from 32% to 42% and ongoing cost control...
Centogene_Logo.png
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
December 22, 2022 16:00 ET | Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
Centogene_Logo.png
CENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results
March 30, 2022 07:30 ET | Centogene NV
- Full Year 2021 Total Revenue Growth of 48%, and 11% in Core Business Segments, Exceeds Guidance - Focus on Pharma and Diagnostics to Position for Strong Performance in 2022 - Closed $62 Million...
Centogene_Logo.png
CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022
March 23, 2022 06:30 ET | Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 23, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to...
Centogene_Logo.png
CENTOGENE Reports Third Quarter 2021 Financial Results
November 24, 2021 07:35 ET | Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
NubevaLogoFull.jpg
Nubeva Announces Q2 Fiscal 2021 Financial Results
December 16, 2020 07:00 ET | Nubeva Technologies
SAN JOSE, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Nubeva Technologies Ltd. ("Nubeva" or the "Company") (TSX-V: NBVA), announces its unaudited consolidated financial statements for the second...